Financial News
Catalyst Pharm Inc (NQ: CPRX )
Price and Volume
Detailed Quote| Volume | 807,681 |
| Open | 21.21 |
| Bid (Size) | 20.97 (2) |
| Ask (Size) | 21.54 (5) |
| Prev. Close | 21.15 |
| Today's Range | 20.87 - 21.21 |
| 52wk Range | 13.00 - 24.27 |
| Shares Outstanding | 102,780,151 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
BioNTech Stock Got A IBD RS Rating Lift
November 14, 2024
NASDAQ:CPRX is an undervalued gem with solid fundamentals.
November 12, 2024
A Peek at Catalyst Pharmaceuticals's Future Earnings
November 05, 2024
Vericel Stock Sees RS Rating Shoot Higher
November 11, 2024
Smaller Cap Biotechs Are In Season: How Are We Doing?
November 07, 2024
NASDAQ:CPRX, a growth stock which is not overvalued.
October 30, 2024
NASDAQ:CPRX is showing good growth, while it is not too expensive.
September 13, 2024
Biotech Momentum Trades For The Q4 Rally
October 29, 2024
Amphastar Casts Wide Net, Hauls In Profits, Gets Rating Upgrade
October 15, 2024
Alkermes Stock Jumps Nearly 30% In 3 Months Amid Hefty Profits
October 14, 2024
A Biotech Breakout Will Be Led By Small Caps
September 23, 2024
Why NASDAQ:CPRX Is a Standout High-Growth Stock in a Consolidation Phase.
September 19, 2024
Keros Therapeutics Stock Meets 80-Plus RS Rating Benchmark
September 05, 2024
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
